Endothelium and hemorheology

Clinical Hemorheology and Microcirculation

Volumn 30, Issue 3-4, 2004, Pages 289-295

  Turchetti, V ^a   Boschi, L ^a   Donati, G ^a   Borgogni, G ^a   Coppola, D ^a   Dragoni, S ^a   Bellini, M A ^a   Sicuro, S ^a   Mastronuzzi, V M A ^a   Forconi, S ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BIOLOGICAL MARKER; CITRULLINE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ADULT; AGED; BIOSYNTHESIS; BLOOD RHEOLOGY; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; ENDOTHELIUM LESION; ENZYME ACTIVITY; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOCONCENTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISCHEMIA; MALE; METHODOLOGY; PHYSICAL STRESS; PRECURSOR; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ADULT; AGED; ENDOTHELIUM, VASCULAR; EXERCISE TEST; FEMALE; HEMORHEOLOGY; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; REFERENCE VALUES; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR DISEASES;

EID: 3242684135     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (61)

1. T. Di Perri, S. Forconi, F. Di Lollo and G. Pozza, Le sindromi di iperviscosità ematica: fisiologia, patologia e clinica, Il Policlinico Sez. Prat. 90 (1983), 576.
2. G.D.O. Lowe, Blood viscosity, lipoptroteins, and cardiovascular risk, Circulation 85(6) (1992), 2329-2331.
3. S. Forconi, Regional ischemia and hyperviscosity, Clin. Hemorheol. 8 (1988), 321.
4. S. Carroll, C.B. Cooke and R.J. Butterly, Plasma viscosity and its biochemical predictors: associations with lifestyle factors in healthy middle-aged men, Blood Coagul. Fibrinolysis 11(7) (2000), 609-16.
5. Y. Tsuda, K. Satoh, M. Kitadai and T. Takahashi, Hemorheologic profiles of plasma fibrinogen and blood viscosity from silent to acute and chronic cerebral infarctions, J. Neurol. Sci. 147(1) (1997), 49-54.
6. S. Forconi, V. Turchetti, R. Cappelli, M. Guerrini and M. Bicchi, Haemorheological disturbances and possibility of their correction in cerebrovascular diseases, J. Mal. Vasc. 24(2) (1999), 110-6 (Review).
7. N. Antonova and I. Velcheva, Hemorheological disturbances and characteristic parameters in patients with cerebrovascular disease, Clin. Hemorheol. Microcirc. 21(3-4) (1999), 405-8.
8. B. Turczynski, K. Pierzchala, L. Slowinska and J. Becelewski, Dynamics of the changes of blood and plasma rheological properties in ischaemic stroke, Wiad. Lek. 55(3-4) (2002), 189-96.
9. B. Turczynski, L. Slowinska, S. Szczesny, M. Baschton, A. Bartosik-Baschton, J. Szygula, J. Wodniecki and J. Spyra, The whole blood and plasma viscosity changes in course of acute myocardial infarction, Pol. Arch. Med. Wewn. 108(4) (2002), 971-8.
10. T.L. De Backer, M. De Buyzere, P. Segers, S. Carlier, J. De Sutter, C. Van de Wiele and G. De Backer, The role of whole blood viscosity in premature coronary artery disease in women, Atherosclerosis 165(2) (2002), 367-73.
11. V. Turchetti, M.A. Bellini, D. Ricci, A. Lapi, G. Donati, L. Boschi, L. Trabalzini, M. Guerrini and S. Forconi, Spontaneous echo-contrast as an in vivo indicator of rheological imbalance in dilatative cardiomyopathy, Clin. Hemorheol. Microcirc. 25(3-4) (2001), 119-25.
12. T.S. Church, C.J. Lavie, R.V. Milani and G.S. Kirby, Improvements in blood rheology after cardiac rehabilitation and exercise training in patients with coronary heart disease, Am. Heart J. 143(2) (2002), 349-55.
13. S. Forconi, M. Guerrini, D. Agnusdei, F. Laghi Pasini and T. Di Perri, Abnormal blood viscosity in Raynaud's phenomenon, Lancet II (1976), 586.
14. P.L. Capecchi, F.L. Pasini, G. Cati, M. Colafati, A. Acciavatti, L. Ceccatelli, S. Petri, A. de Lalla and T. Di Perri, Experimental model of short-time exercise-induced preconditioning in POAD patients, Angiology 48(6) (1997), 469-80.
15. C. Koksal, M. Ercan and A.K. Bozkurt, Hemorrheological variables in critical limb ischemia, Int. Angiol. 21(4) (2002), 355-9.
16. S. Forconi, M. Guerrini, D. Pieragalli, A. Acciavatti, C. Del Bigo, C. Galigani and T. Di Perri, Le alterazioni emoreologiche nella cardiopatia ischemica, La Ricerca Clin. Lab. 13(Suppl. 3) (1983), 195.
17. V. Turchetti, D. Ricci, F. Leoncini, M. Bianconi, V. Trani, M. Bellini, F. Petri, L. Trabalzini and S. Forconi, Red cell morphology, blood viscosity and intraerythrocytic calcium after exercise test in normal subjects and in patients suffering from vascular disease, Clin. Hemorheol. Microc. 20 (1999), 285.
18. ++ content of blood cells in exercising ischaemic limbs, Clin. Hemorheol. 12 (1999), 527-534.
19. V. Turchetti, C. De Matteis, F. Leoncini, L. Trabalzini, M. Guerrini and S. Forconi, Variations of erythrocyte morphology in different pathologies, Clin. Hemorheol. Microcirc. 17(3) (1997), 209-215.
20. V. Turchetti, F. Leoncini, C. De Matteis, L. Trabalzini, M. Guerrini and S. Forconi, Evaluation of erythrocyte morphology as deformability index in patients suffering from vascular diseases, with or without diabetes mellitus: correlation with blood viscosity and intra-erythrocytic calcium, Clin. Hemorheol. Microcirc. 18(2) (1998), 141-149.
21. T.F. Luscher and M. Barton, Biology of endothelium, Clin. Cardiol. 20 (Suppl. II) (1997), II3-II10.
22. H. Haller, Endothelial function. General considerations, Drugs 53 (Suppl. 1) (1997), 1-10.
23. J.R. Vane, E.E. Anggard and R.M. Botting, Regulatory functions of the vascular endothelium, N. Engl. J. Med. 323 (1990), 27-36.
24. E.E. Anggard, The regulatory functions of the endothelium, Jpn. J. Pharmacol. 58 (Suppl. 2) (1992), 200P-206P.
25. E.E. Anggard, The endothelium - the body's largest endocrine gland?, J. Endocrinol. 127(3) (1990), 371-5.
26. V. Mollace, D. Salvemini, E. Anggard and J. Vane, Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase, J. Pharmacol. 104(3) (1991), 633-8.
27. T. Koga, W.Y. Zhang, T. Gotoh, S. Oyadomari, H. Tanihara and M. Mori, Induction of citrulline-nitric oxide (NO) cycle enzymes and NO production immunostimulated rat RPE-J cells, Exp. Eye Res. 76(1) (2003), 15-21.
28. E.E. Anggard, R.M. Botting and J.R. Vane, Endothelins, Blood Vessels 27(2-5) (1990), 269-81.
29. A. Lerman, E.K. Sandok, F.L. Hildebrand Jr. and J.C. Burnett Jr., Inhibition of endolhelium-derived relaxing factor enhances endothelin-mediated vasoconstriction, Circulation 85(5) (1992), 1894-8.
30. H. Shimokawa, Primary endothelial dysfunction: atherosclerosis, J. Mol. Cell. Cardiol. 31(1) (1999), 23-37.
31. G.H. Gibbons and V.J. Dzau, The emerging concept of vascular remodeling, N. Engl. J. Med. 330(20) (1994), 1431-8.
32. J. Martens-Lobenhoffer and S.M. Bode-Boger, Simultaneous detection of arginine, asymmetric dimethylarginine, symmetric dimethylarginine and citrulline in human plasma and urine applying liquid chromatography-mass spectrometry with very straightforward sample preparation, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 798(2) (2003), 231-9.
33. N.M. Moyna and P.D. Thompson, The effect of physical activity on endothelial function in man, Acta Physiol. Scand. 180(2) (2004), 113-23.
34. A.E. Pontiroli, P. Pizzocri, D. Koprivec, P. Vedani, M. Marchi, C. Arcelloni, R. Paroni, K. Esposito and D. Giugliano, Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans, Eur. J. Endocrinol. 150(2) (2004), 195-200.
35. A. Maiorana, G. O'Driscoll, R. Taylor and D. Green, Exercise and the nitric oxide vasodilator system, Sports Med. 33(14) (2003), 1013-35.
36. S. Maeda, T. Tanabe, T. Miyauchi, T. Otsuki, J. Sugawara, M. Iemitsu, S. Kuno, R. Ajisaka, I. Yamaguchi and M. Matsuda, Aerobic exercise training reduces plasma endothelin-1 concentration in older women, J. Appl. Physiol. 95(1) (2003), 336-41.
37. D.T. Smith, G.L. Hoelzer, J.J. Greiner, B.L. Stauffer and C.A. DeSouza, Effects of ageing and regular aerobic exercise on endothelial fibrinolytic capacity in humans, J. Physiol. 546(Pt 1) (2003), 289-98.
38. S. Maeda, T. Miyauchi, T. Kakiyama, J. Sugawara, M. Iemitsu, Y. Irukayama-Tomobe, H. Murakami, Y Kumagai, S. Kuno and M. Matsuda, Effects of exercise training of 8 weeks and detraining on plasma levels of endothelium-derived factors, endothelin-1 and nitric oxide, in healthy young humans, Life Sci. 69(9) (2001), 1005-16.
39. H. Dayoub, V. Achan, S. Adimoolam, J. Jacobi, M.C. Stuehlinger, B.Y. Wang, P.S. Tsao, M. Kimoto, P. Vallance, A.J. Patterson and J.P. Cooke, Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis. Genetic and physiological evidence, Circulation 108(24) (2003), 3042-7.
40. W.H. Reinhart, G. Dziekan, U. Goebbels, J. Myers and P. Dubach, Influence of exercise training on blood viscosity in patients with coronary artery disease and impaired left ventricular function, Am. Heart J. 135(3) (1998), 379-382.
41. S. Gielen, G. Schuler and R. Hambrecht, Exercise training in coronary artery disease and coronary vasomotion, Circulation 103(1) (2001), E1-6.
42. B. Rosen, J. Barg and R. Zimlichman, The effects of angiotensin II, endothelin-1, and protein kinase C inhibitor on DNA synthesis and intracellular calcium mobilization in vascular smooth muscle cells from young normotensive and spontaneously hypertensive rats, Am. J. Hypertens. 12(12 Pt 1-2) (1999), 1243-51.
43. M. Rattazzi, M. Puato, E. Faggin, B. Bertipaglia, F. Grego and P. Pauletto, New markers of accelerated atherosclerosis in end-stage renal disease, J. Nephrol. 16(1) (2003), 11-20.
44. C. Benedetto, L. Marozio, I. Neri, M. Giarola, A. Volpe and F. Facchinetti, Increased L-citrulline/L-arginine plasma ratio in severe preeclampsia, Obstet. Gynecol. 96(3) (2000), 395-9.
45. J. Heger, A. Godecke, U. Flogel, M.W. Merx, A. Molojavyi, W.N. Kuhn-Veiten and J. Schrader, Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction, Circ. Res. 90(1) (2002), 93-9.
46. T. Hori, T. Matsubara, T. Ishibashi, K. Ozaki, K. Tsuchida, T. Mezaki, T. Tanaka, A. Nasuno, K. Kubota, Y. Nakamura, M. Yamazoe, Y. Aizawa and M. Nishio, Significance of asymmetric dimethylarginine (ADMA) concentrations during coronary circulation in patients with vasospastic angina, Circ. J. 67(4) (2003), 305-11.
47. T. Hedner, A. Himmelmann and L. Hansson, Homocysteine and ADMA - emerging risk factors for cardiovascular disease?, Blood Press 11(4) (2002), 197-200.
48. S. Forconi, M. Guerrini, R. Cappelli, P. Sani and L. Furesi, Rapporti tra endotelio e cellule circolanti a livello microcircolatorio: influenza su coagulazione, fibrinolisi, motilità della parete vascolare ed emoreologia. Microcircolazione 1989: XIV Congresso Nazionale della Società Italiana di Microangiologia e Microcircolazione (atti), pp. 145-151.
49. J. Figueras, Y. Monasterio, R.M. Lidon, E. Nieto and J. Soler-Soler, Thrombin formation and fibrinolytic activity in patients with acute myocardial infarction or unstable angina: in-hospital course and relationship with recurrent angina at rest, J. Am. Coll. Cardiol. 36(7) (2000), 2044-6.
50. J.F. Stoltz, M. Boisseau, S. Muller, X. Wang, S. Legrand and M.V. Labrador, Hemorheology and vascular endothelial cells, J. Mal. Vasc. 24(2) (1999), 99-109.
51. V. Turchetti, M.A. Bellini, L. Boschi, G. Postorino, A. Pallassini, M.G. Richichi, L. Trabalzini, M. Guerrini and S. Forconi, Haemorheological and endothelial-dependent alterations in heart failure after ACE inhibitor, calcium antagonist and beta blocker, Clin. Hemorheol. Microcirc. 27(3-4) (2002), 209-18.
52. T. Gori and J.D. Parker, Nitrate tolerance: a unifying hypothesis, Circulation 106(19) (2002), 2510-3.
53. U. Jurt, T. Gori, A. Ravandi, S. Babaei, P. Zeman and J.D. Parker, Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study, J. Am. Coll. Cardiol. 38(3) (2001), 854-9.
54. J. Vasquez-Vivar, B. Kalyanaraman, P. Martasek, N. Hogg, B.S. Masters, H. Karoui, P. Tordo and K.A. Pritchard Jr., Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors, Proc. Natl. Acad. Sci. USA 95(16) (1998), 9220-5.
55. J.M. Hill, G. Zalos, J.P. Halcox, W.H. Schenke, M.A. Waclawiw, A.A. Quyyumi and T. Finkel, Circulating endothelial progenitor cells, vascular function, and cardiovascular risk, N. Engl. J. Med. 348(7) (2003), 593-600.
56. J. Heger, A. Godecke, U. Flogel, M.W. Merx, A. Molojavyi, W.N. Kuhn-Velten and J. Schrader, Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction, Circ. Res. 90(1) (2002), 93-9.
57. R.H. Boger, S.M. Bode-Boger, A. Szuba, P.S. Tsao, J.R. Chan, O. Tangphao, T.F. Blaschke and J.P. Cooke, Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia, Circulation 98(18) (1998), 1842-7.
58. J.P. Cooke, Does ADMA cause endothelial dysfunction?, Arterioscler. Thromb. Vasc. Biol. 20(9) (2000), 2032-7.
59. C. Hermenegildo, P. Medina, M. Peiro, G. Segarra, J.M. Vila, J. Ortega and S. Lluch, Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients, J. Clin. Endocrinol. Metab. 87(12) (2002), 5636-40.
60. A. Pettersson, L. Uggla and V. Backman, Determination of dimethylated arginines in human plasma by high-performance liquid chromatography, J. Chromatogr. B Biomed. Sci. Appl. 692(2) (1997), 257-62.
61. S. Taddei, L. Ghiadoni, A. Virdis, D. Versari and A. Salvetti, Mechanisms of endothelial dysfunction: clinical significance and preventive non-pharmacological therapeutic strategies, Curr. Pharm. Des. 9(29) (2003), 2385-402.